to D farinae, and 74% increased odds of sensitization to rat urinary protein (Table II) . Similar results were found for + 2mol PAH. Notably, the number of subjects sensitized to rat urinary protein (n 5 29 or 1%) was small. No significant associations were found with any of the other allergens or for + 3,4mol PAH. We found no significant interaction between urinary PAH and allergen levels on sensitization to cockroach, D farinae, or rat urinary protein (see Table E2 in this article's Online Repository at www.jacionline.org).
Our results expand those of previous analyses in NHANES, in which PM 2.5 was associated with sensitization to indoor allergens but not to outdoor allergens 5 (PAHs are components of PM 2.5 ). In one study, having high urinary PAH metabolites at both ages 5 and 9 years was more significantly associated with cockroach sensitization than having high PAH at either time point, 6 suggesting that persistent PAH exposure may be particularly relevant to cockroach allergy. Consistent with these results, we found that PAH was significantly associated with cockroach sensitization. In contrast to our results for mouse allergy, urinary PAH metabolites measured at age 5 years were significantly associated with mouse sensitization at age 5 years in a previous study of inner-city children. 4 This could be explained by differences in the prevalence of sensitization to mouse urinary protein between our study (1%) and that previous report (ie, 14% at age 9 years 6 ). Our data seem driven primarily by naphthalene, which (as in previous studies 4, 7 ) comprises the largest average percent of total PAH concentration (see Table E3 in this article's Online Repository at www.jacionline.org). Although using urinary PAH metabolites is beneficial in aggregating exposure from all routes (respiratory, skin, gastrointestinal), specific routes may be more important for allergic sensitization. Naphthalene exposure has been reported to occur almost exclusively by inhalation, with only approximately 2% in the particulate phase. 2 Thus, vaporous PAH may be more likely to reach the distal airways. An additional limitation of urinary PAH measures is that differences in the metabolism of parent PAH compounds, from intraindividual metabolism differences to intrinsic parent PAH differences, could result in preferential tissue secretion of certain PAHs (eg, higher molecular weight PAHs more excreted in feces 7, 8 ). Moreover, air pollution is a heterogeneous mixture, and thus naphthalene may be a surrogate marker of other unmeasured exposures.
The cross-sectional design of our study precludes causal inferences, and the timing of PAH measurements (ie, prenatal vs postnatal) may be important. Perzanowski et al 9 found that increased prenatal exposure to + 8 PAH nonvolatile modified the effect of cockroach allergen on cockroach sensitization in children, particularly in those with null genotype for glutathione S-transferase M1 (GSTM1). 9 We did not find a significant interaction between postnatal cockroach allergen exposure and urinary PAH metabolites on cockroach sensitization. Although we used a single PAH measurement, estimated to reflect exposure in the previous 24 to 72 hours, 8 comparison to previous NHANES cycles suggests similar exposure levels across NHANES cohorts (see Table E4 in this article's Online Repository at www.jacionline.org).
In summary, + mol PAH and + 2mol PAH were associated with cockroach, dust mite, and rat sensitization in a large US representative sample. Given the ubiquity of PAHs and the importance of allergic sensitization in atopic diseases, our findings are highly relevant to public health and should further encourage investigation into molecular mechanisms and environmental exposure routes, as well as policies aimed at promoting clean air in the United States and worldwide. such as the skin microbiota, have been described as risk factors for AD. 3, 4 Reduction of microbiome diversity, accompanied by an increase in Staphylococcus aureus abundance, as well as S aureus enterotoxins and exotoxins, have been shown to correlate with disease severity. 5 Furthermore, epidermal barrier dysfunction is an essential factor related to the pathogenesis of AD. Previous studies of skin of patients with AD have shown disruption of the skin barrier (eg, filaggrin, claudin-1, claudin-4, and claudin-23) in terms of both gene expression and protein localization. 6 In this study we pursued a ''joint-omics'' approach, aiming to uncover possible correlations between the skin microbiome and the skin transcriptome in the context of AD.
Gene expression (RNA sequencing [RNAseq] ) analysis was performed on matched lesional and nonlesional skin tissue biopsy specimens from patients with AD and healthy subjects.
In parallel, 16S DNA sequencing and microbiome analysis were performed on skin swabs collected from the same place in the same patients with AD and healthy subjects (see workflow and detailed patient and sample information in Fig E1 and Table E1 in this article's Online Repository at www.jacionline. org). Tissue biopsy specimens from patients with AD were taken from an upper-arm lesion and a nonlesional site located in close proximity but at least 10 cm away from the lesion and from the upper arm and/or lower back region from healthy subjects.
b-Diversity analysis (multidimensional scaling) of the global skin microbiome shows the healthy microbiome to cluster separately from the AD microbiome, with no significant difference between lesional and nonlesional skin (Fig 1, A) . On the other hand, b-diversity analysis (principal component analysis [PCA]) of the global skin transcriptome shows that skin samples from patients with lesional AD cluster separately compared with samples from patients with nonlesional AD and those from healthy skin (Fig 1, B) . Neither the microbiome nor transcriptomic differences were dependent on sex or age variables. More detailed hierarchical clustering and 3-dimensional PCA and nonmetric multidimensional scaling (NMDS) analyses of both data sets are shown in Fig E2 in this article's Online Repository at www.jacionline.org.
Global analysis of microbiome distribution reveals that Staphylococcaceae is the only family with a significantly increased frequency in patients with AD compared with healthy subjects and a significantly greater frequency in lesional compared with nonlesional skin (Fig 1, C) . S aureus is the most abundant operational taxonomic unit (OTU) in AD skin and is significantly greater in lesional compared with nonlesional skin. However, S aureus is found in only 40% of the healthy samples with a significantly lower frequency. In contrast, Staphylococcus epidermidis has significantly greater frequency in nonlesional compared with lesional skin and a lower frequency in healthy skin samples. We observed that S aureus and S epidermidis are significantly negatively correlated with each other in lesional skin and for all AD samples (see Fig E3, C, in this article's Online Repository at www.jacionline.org). In general, in the samples from patients with AD, S aureus is significantly negatively correlated with the 4 other most abundant Staphylococcus species, which show positive correlation with each other (see Fig E3,  D) . Analysis of the 7 most abundant Staphylococcus species frequencies in skin is shown in Fig E3, Table E2 , and the Results section in this article's Online Repository at www.jacionline.org.
Global skin transcriptome Gene Ontology and Kyoto Encyclopedia of Genes and Genomes analyses based on the 2000 most significant lesional versus nonlesional differentially expressed genes, revealed that cell adhesion, cadherin signaling, and keratinization are among the most differentially expressed gene groups in patients with AD (Fig 1, D , and see Table E3 in this article's Online Repository at www.jacionline.org). Therefore we analyzed differential expression of the 5 skin barrier gene families (see Figs E4 and E5 and the Results section in this article's Online Repository at www.jacionline.org): tight junctions (TJs), stratum corneum (SC), gap junctions (GJs), desmosomes, and adherens junctions (AJs). Overall, the data show a significant downregulation of major barrier molecules in AD lesions together with initiation of a healing process for certain keratins, GJs, desmosomes, and AJs (details in Figs E4 and E5) .
Finally, we correlated the frequency of the various Staphylococcus species on the skin with expression levels of the various skin barrier genes in each sample. To avoid false discovery of correlations caused by the large number of tests performed, we used a shuffling bootstrap approach to test the robustness of the correlations (see details in the Methods section in this article's Online Repository at www.jacionline.org). Only correlations with r 5 1 and P < .017 had probability of greater than 99% to be real according to the bootstrap results and were defined here as multiple testing corrected (MTC) correlations. Of the 135 skin barrier genes tested, only 2 TJ genes were proved to have MTC correlations with more than 1 Staphylococcus species. Both CLDN4 and TJP1 gene expression levels were negatively MTC correlated with S aureus and positively MTC correlated with S epidermidis in lesional samples but not in nonlesional samples (Fig 2, A-D) . In addition, an MTC-positive correlation was also found between Staphylococcus haemolyticus and CLDN4 and TJP1 and between Staphylococcus hominis and CLDN5 in lesional samples (Fig 2, E-G) . Interestingly, all 4 major Staphylococcus species were correlated (S aureus negatively and S epidermidis, S hominis, and S haemolyticus positively) with 2 couples of related genes (CLDN4 and CLDN5; TJP1 and TJP2) either by the abovementioned MTC correlations or by a non-MTC significant correlation (r > 0.8 and P < _ .05: Fig 2, E-H) . Lastly, 6 additional MTC correlations were identified between single Staphylococcus species and other TJ genes (see Table E4 in this article's Online Repository at www.jacionline.org).
The main result of this study is the correlation between the Staphylococcus species-dominated dysbiosis in the skin microbiome with dysregulation of the skin barrier transcriptome in patients with AD. In particular, there was a correlation in lesional skin, but not nonlesional skin, among all 4 major Staphylococcus species (S aureus negatively and S epidermidis, S hominis, and S haemolyticus positively) and only 4 TJ genes (CLDN4, CLDN5, TJP1, and TJP2). Because correlations do not necessarily imply a causative relation, we cannot make definitive conclusions on whether the microbiome dysbiosis is the cause for or result of the skin barrier defect. 7 All 5 skin barrier gene families show significant expression changes in lesional and nonlesional AD skin, which is consistent with previous publications. 8 However, we find a correlation with staphylococci abundance with RNA expression of only 4 TJ genes, possibly because claudin-4 and zonula occludens-1 (ZO-1) (the protein product of TJP1) are expressed at the surface of the top epidermis layer. 6 An alternative hypothesis would be that changes in the most highly expressed proteins (eg, CLDN1 and OCLN) could still leave sufficient levels of that specific protein, whereas changes in levels of proteins with medium-level expression (eg, claudin-4/5 and ZO-1/2) could produce relatively low protein levels, thus giving rise to a significant relation with staphylococci abundance. The last possible explanation is that S aureus has a specific relation with these 4 TJ proteins, as observed for claudin-4. 9 In summary, this study allowed us to better characterize concomitantly the state of microbiome and epidermal barrier dysregulation in AD skin. We identified 4 TJ genes with expression that is robustly correlated to the microbiome dysbiosis in patients with AD. A larger validation study is needed to confirm (Fig 1,  B) differentiates between skin samples form patients with lesional versus nonlesional AD and healthy skin; the latter 2 are not well differentiated. C, Staphylococcaceae is the only family that is significantly (P 5 .003) more abundant in samples from patients with AD, revealing Staphylococcus speciesdominated dysbiosis. D, Heat map Gene Ontology (GO) analysis of the top 2000 significantly differentially expressed genes in patients with lesional versus nonlesional AD shows that cadherin signaling, adhesion molecules, and keratinization are among the most significant GO terms associated with AD. The most significant GO terms associated with 6 gene clusters in the top 2000 differentially expressed genes are presented with their P values and gene overlap numbers in the table. The scale for the NMDS distance A-D, An MTC-negative correlation is observed in lesional (LS; red) skin between S aureus frequency and the expression level of the TJ genes CLDN4 (Fig 2, A) and TJP1 (Fig 2, B) , whereas MTC-positive correlation is observed between S epidermidis and the same genes (Fig 2, C and D) . However, in nonlesional (NL) skin (blue) there is no correlation between Staphylococcus species and these TJ genes. The relation between lesional and nonlesional paired samples (dotted black lines) shows the same direction as the correlation between lesional samples for CLDN4 (Fig 2, A and C) but the inverse direction for TJP1 (Fig 2, B and D) . E-H, In fact, in lesional skin all 4 major Staphylococcus species (S aureus in red, S epidermidis in light blue, S hominis in green, and S haemolyticus in purple) show correlation with CLDN4 (Fig 2, E) and TJP1 (Fig 2, F) , as well as with CLDN5 (Fig 2, G) and TJP2 (Fig 2, H) . Solid lines depict MTC correlations with r 5 1 and P < .017. Dashed lines depict correlations with r > 0.8 and P < .05. Dash-dotted lines depict trends for correlations.
our results, and further proteomics and functional studies are needed to elucidate the role these genes play in relation to changes in Staphylococcus species and skin barrier dysfunction in general.
As a general conclusion, we postulate that the explanation for AD flare development and exacerbation is a complex interaction between the skin microbiota, barrier, and immune system. Interaction points between different components of human skin might be the key to development of therapeutic approaches to allergic skin diseases. Fc3RI cross-linking and IL-3 protect human basophils from intrinsic apoptotic stress
To the Editor: Basophils are armed with proinflammatory mediators that are detrimental during IgE-mediated allergic reactions. Stimuli present in an allergic inflammatory milieu, such as IL-3, are known for extending the lifespan of basophils and eosinophils. 1 Several studies have suggested that induction of apoptosis, which is critical for the resolution of inflammation, is poorly managed in allergic airway inflammation, such as in the case of eosinophils in patients with acute asthma. 2 In this study we aimed to investigate the underlying mechanism regulating survival in human basophils under noninflammatory and allergic conditions, respectively. We focused on the study of antiapoptotic B-cell lymphoma 2 (Bcl-2) family members, which control the intrinsic pathway of apoptosis. The relevance of key antiapoptotic Bcl-2 family members in primary human basophils was evaluated by using small-molecule inhibitors termed Bcl-2 homology domain 3 (BH3) mimetics, which specifically inhibit Bcl-2 (ABT-199/venetoclax [Venclaxta]), myeloid cell leukemia 1 (Mcl-1; A-1210477), or Bcl-2 and B-cell lymphoma-extra large (Bcl-xL; ABT-263/navitoclax). 3, 4 Because all 3 types of granulocytes are developmentally related but differ in their expression profiles of Bcl-2 family members (see Fig E1, A, and the Methods section in this article's Online Repository at www.jacionline.org), eosinophils and neutrophils were used as comparisons.
Our data showed that unlike eosinophils and neutrophils, basophils are highly susceptible to the inhibition of Bcl-2 (Fig 1, A) . This confirmed our previously published study in which we demonstrated that survival of mouse basophils was also highly dependent on Bcl-2. 5 Simultaneous inhibition of Bcl-2 and Bcl-xL further increased the cell death rate in basophils but also efficiently induced apoptosis in eosinophils (Fig 1, A) . In basophils titration experiments demonstrated that ABT-199 was more potent in inducing cell death than ABT-263, with the half-maximal effective concentration being 9 and 35 nmol/L, respectively (see Fig E2, A, in this article's Online Repository at www.jacionline.org and the Methods section in this article's Online Repository). Accordingly, eosinophil survival was reduced by 50% in response to 28 nmol/L ABT-263 (see Fig E2, A) .
Short-term evaluation of BH3 mimetics on basophils revealed that, although less potent, ABT-263 triggered cell death more rapidly than ABT-199, as evidenced by a significant induction of cell death after only 2 hours (see Fig E2, B) . This was coherent with reduced protein levels of X-linked inhibitor of apoptosis (XIAP), an endogenous inhibitor of initiator and effector caspases, 6 in ABT-263-treated basophils compared with cells exposed to ABT-199 (Fig 1, C) . Compared with basophils, ABT-263 induced cell death in eosinophils with a certain delay, which was unexpected because eosinophils are known to have a shorter spontaneous lifespan than basophils (see Fig E2, B) . None of the tested inhibitors significantly accelerated cell death of neutrophils (Fig 1, A, and see Fig E2, C) , and hence the variable endogenous expression of antiapoptotic Bcl-2 family members among granulocytes reflects their susceptibility to these BH3 mimetics.
METHODS

Patient recruitment and sampling
The Ethical Committee of the Technical University of Munich approved all human subject recruitment and sample collection. Exclusion criteria included self-reported antibiotic treatment (oral or systemic) 6 months before enrollment. Subjects were included only if no topical steroids or other treatment was used in the last 4 weeks before sampling. Additionally, patients were instructed not to use hand sanitizers, antimicrobial soaps, and skin care products and not to shower at least 12 hours before the sample collection appointment.
A total of 13 chronic-phase patients with AD with a lesion in the upper arm (mean SCORAD score, 57.3; range, 32-99.5) and 7 healthy control subjects were included in the study (Fig E1 and see characteristics in Table E1 ). Both swabs for microbiome analysis and 4-mm biopsy specimens for transcriptomics analysis were taken from the middle of the lesion in the area of the upper arm area and from an adjacent nonlesion area with at least 10 cm distance to the outer shape of the visible lesion. Swabs and biopsy specimens from healthy donors were taken from the upper arm and/or lower back region, with no significant difference in staphylococci frequencies.
Collection and processing of skin swabs and microbiome sequencing
Cutaneous swabs (Sigma-Swab, Medical Wire; Corsham, Wiltshire, United Kingdom) were collected, as described previously, E1,E2 and stored at 2808C. For DNA extraction, swabs were transferred to a bead-beating tube with 500 mg of 0.1-mm zirconium glass beads (Carl Roth, Karlsruhe, Germany), and the QIAamp UCP Pathogen Kit (Qiagen, Hilden, Germany) was used. The original tube was rinsed with 650 mL of lysis buffer, which was then transferred to the swab tube. Samples were incubated for 10 minutes at 568C with continuous shaking and mechanically lysed with FastPrep (MP Biomedicals, Santa Ana, Calif) twice for 20 seconds at 4.0 m/s, with a 1-minute break between runs. The lysate was processed according to the QIAamp UCP Pathogen Mini Kit preparation protocol. DNA samples were amplified by using variable regions 1 to 3 of the 16S RNA gene to be able to separate different Staphylococcus species. E3 All samples were equimolarly pooled into one library by using 2 multiplexing barcodes per samples. Bidirectional sequencing with a MiSeq Nano v3 (Illumina, San Diego, Calif) resulted in 23 300-bp pairedend reads. At each sampling, swab controls without any skin contact were processed parallel to experimental samples. No significant background contamination was observed from either reagents, collection procedures, or both.
Primary microbiome data analysis, including signal processing, demultiplexing, and trimming of adapter sequences, was performed by using MiSeq Reporter 2.5.0.5 software. Thereafter, the bioinformatics software tool CLC Genomics Workbench 8.5.1 with the Microbial Genomics Module (Qiagen) was used for quality trimming, merging, and clustering. OTUs were clustered at a 97% identity threshold, according to the taxonomy of the SILVA 16S rRNA sequence database (www.arb-silva.de). OTUs of interest were reidentified by using EzBioCloud for similarity-based searches against qualitycontrolled databases of 16S rRNA sequences to identify specific species, especially Staphylococcus species.
E4
Collection and processing of skin biopsy specimens and transcriptome sequencing Punch biopsy specimens (4 mm) were immediately transferred in RNAlater solution (Life Technologies, Carlsbad, Calif) at 48C overnight and thereafter stored at 2808C. Total RNA was prepared from whole skin tissue by using the RNeasy Mini Kit (Qiagen). Quantity and quality of the isolated RNAs were determined with a Qubit (1.0) Fluorometer (Life Technologies) and a 2100 Bioanalyzer (Agilent, Waldbronn, Germany), and samples with RNA integrity numbers of greater than 7.0 were chosen for sequencing. Library preparation for RNAseq was performed with the TruSeq Stranded mRNA Sample Prep Kit (Illumina), and the Illumina HiSeq 2500 single end 126 or 101 bp (Illumina) was used for sequencing.
16S recombinant RNAseq
All samples were amplified with the Primers 8F-YM (59-AGAGTTTGA-TYMTGGCTCAG-39) and 517R (59-ATTACCGCGGCTGCTGG-39). E5 The amplicons cover the variable regions 1 to 3 of the 16S RNA gene. Each amplicon was purified separately, applying solid-phase reversible immobilization paramagnetic bead-based technology (AMPure XP beads; Beckman Coulter, Fullerton, Calif) with a bead/DNA ratio of 0.7:1 (vol/vol), according to the manufacturer's instructions. Normalization of each amplification product to approximately 1 ng/mL DNA was achieved by using the SequalPrep Kit (Life Technologies).
A library was generated containing each of the amplicons from the 16S PCRs. Additionally, 2 positive controls and 2 negative controls were also added to the pool. All samples except the controls were pooled equimolarly to form one library. The High Sensitivity DNA LabChip Kit (Agilent Technologies) was used on the 2100 Bioanalyzer (Agilent Technologies) to analyze the quality of the purified amplicon library. Bidirectional sequencing with an MiSeq Reagent Kit 600-cycles Nano v3 (Illumina) results in reads of 300 bases in both directions, totaling 600 bases of sequence information in 23 300-bp paired-end reads. The Illumina software MiSeq Reporter 2.5.0.5 on the MiSeq system and the Illumina Sequence Analysis Viewer 1.9.1 were used for imaging and evaluation of the sequencing run performance.
Primary analysis of microbiome data
Primary microbiome data analysis, including signal processing, demultiplexing, and trimming of adapter sequences of the 2 read files was performed with the MiSeq inherited MiSeq Reporter 2.5.0.5 software. Furthermore, data were imported in the bioinformatics software tool CLC Genomics Workbench 8.5.1 (Qiagen) for quality trimming, merging of reads 1 and 2 from each cluster, and quality control report generation. Clustering (OTU definition) was also performed with the CLC plugin Microbial Genomics Module.
Demultiplexed raw data (reads 1 and 2 per sample) were imported into CLC Genomics Workbench as paired-end (forward-reverse) reads. A possible distance between 1 and 10,000 bases was allowed. Failed reads were removed from the data set during this process.
As a first step, read 1 and 2 sequences from every sample were merged by using the overlapping sequence information and taking the minimum overlap, potential mismatches, gaps, and unaligned ends into account. The 2 reads were merged, including a minimum of 20-bp overlaps without mismatch and maximum unaligned end mismatches of 2 bp.
Read trimming was performed according to primer sequences, base quality, and read length, whereby a probability quality limit of .05 was applied. Sequences of less than 400 bp were discarded to guarantee similarity and a sufficiently high level of sequence information for phylogenetic classification, and longer sequences were trimmed down to this length.
The remaining sequences were clustered at a 97% identity threshold defining OTUs according to the taxonomy of the SILVA 16S rRNA sequence database (www.arb-silva.de). Chimeric sequences, representing PCR and sequencing artifacts, were filtered out and discarded during this step.
Whole-transcriptome sequencing
Library preparation for RNAseq was performed by using the TruSeq Stranded mRNA Sample Prep Kit (Illumina). Total RNA samples (1 mg) were ribosome depleted and then reverse transcribed into double-stranded cDNA, with actinomycin added during first-strand synthesis. The cDNA samples were fragmented, end-repaired, and polyadenylated before ligation of TruSeq adapters. The adapters contain the index for multiplexing. Fragments containing TruSeq adapters on both ends were selectively enriched with PCR. The quality and quantity of the enriched libraries were validated by using the Qubit ( 
Bioinformatics analysis of microbiome data
A number of microbiome samples were excluded (see details in Table E1 and Fig E1) from analysis caused by technical problems or low sequencing depth (<1000 reads), resulting in 20 samples in the analysis that show no significant difference in sequencing depth between the 3 skin groups and no dependence of the number of OTUs observed as a function on sequencing depth (Fig E4) . After a normalized OTU table was obtained, the a-diversity of the global microbiome was assessed for each sample by using a number of methods: richness, inverse Simpson index, and normalized Shannon entropy. In addition, we analyzed the frequencies of the most abundant families and species and of specific species of interest (eg, staphylococci). For each OTU, species, and family, we also characterized the span (percentage detectable samples) over all the samples and, more importantly, over each subgroup of samples (ie, lesional, nonlesional, and healthy). b-Diversity analysis of the global microbiome was performed by using multidimensional scaling and hierarchical trees to look for differences between subgroups of patients using the RHEA R-script package. E8 The more detailed analysis of Staphylococcaceae and their correlation with the transcriptome was performed on 22 (of 54) Staphylococcus species-annotated OTUs that had a minimum total abundance of 30 reads and minimum span of 25% over all samples.
Bioinformatics analysis of transcriptome data
A number of transcriptome samples were excluded (see Table E1 and Fig  E1) from analysis because of technical problems or low RNA yield, resulting in 28 samples in the analysis, which show no quality control problems. Geneand isoform-level abundances were quantified as RPKM values. Clustering analyses were performed with the ''ward.D2'' clustering algorithm implemented in the ''hclust'' function of the R statistics package. Heat map plots were performed with the function ''heatmap.2'' implemented in the gplots R package. Differential expression analysis between groups was performed with the edger R bioconductor package. E9 More detailed analysis and correlations tested with the microbiome for the 135 skin barrier genes that were differentially expressed between nonlesional versus lesional skin or between healthy versus nonlesional skin with a false discovery rate of less than 0.01.
Analysis of correlations between microbiome and transcriptome
Because of the extensive multiple testing involved in correlating microbiome data with transcriptome data, we hook a bootstrap approach to correct for false discovery of correlations. Even after focusing on the Staphylococcus species (n 5 7) and skin barrier genes (n 5 135), 945 correlation tests were performed for each skin group. We identified 63 (6.7%) potentially significant (P < .05) correlations, most of them between sporadic Staphylococcus species and sporadic genes. To verify these correlations, we used a bootstrap approach, in which the transcriptome results were randomly shuffled across samples to create 100 random sets of data in which less than 20% of the gene expression levels corresponded to the appropriate microbiome frequency of the same original sample. This process was performed separately for each combination of data sets being correlated (eg, correlating Staphylococcus species with TJ genes and with GJ genes) to maintain the original structure of the data. This approach revealed that an average of 71 (7.5%) correlations in the bootstrap set was seemingly significant (P < .05) but actually arose randomly in the shuffled bootstrap sets because of multiple testing. Only correlations with r 5 1 and P < .017 had probability of greater than 99% to be real according to the bootstrap results and were defined as MTC correlations. Only 13 MTC correlations were found (of the initial 63), and these were found only in lesional skin and only from the TJ family (Table E4) . Indeed, most of the sporadic correlations were found to be non-MTC, whereas 7 (54%) MTC correlations were found to be associated with 3 genes that had correlation with a number of Staphylococcus species (Table E4) .
Statistical analysis
The nonparametric Mann-Whitney (or Kruskal-Wallis) test was used to verify the statistical significance of differences in continuous variables between 2 (or 3) subgroups of samples. The statistical significance of differences in proportions of discrete data between subgroups of samples was tested by using the Fisher exact test. Correlations between continuous variables were assessed by using the nonparametric Spearman test. Significant P values were considered at the 2-tailed level of less than .05 unless correction for multiple testing was needed in which case the false discovery rate results were used or a bootstrap method was used, as described above.
RESULTS
Frequency of Staphylococcus species
In addition to S aureus and S epidermidis, which are the most frequent Staphylococcus species (Table E2) , S hominis frequency is similar between samples from patients with nonlesional AD and healthy subjects, which are both significantly greater than those in lesional skin (Fig E3, A) . Staphylococcus caprae shows a similar pattern like S hominis, as can be seen by the differential abundance patterns in the heatmap (Fig E3, B) . S haemolyticus has the same range of abundance over the 3 skin groups, with a somewhat greater span in samples from healthy subjects versus patients with AD. A significant difference is found also for Staphylococcus warneri, but its abundance is very low.
We did not observe a correlation between Staphylococcus species frequencies and either IgE levels or SCORAD scores of the patients.
Differential expression of skin barrier genes
The majority of highly expressed TJ genes are downregulated in lesional skin, among them claudins 1, 3 to 5, 7 to 11, 16, 19, and 23 and CLDND1 (Fig E4) . Furthermore, claudin-1, F11r, and occludin are significantly downregulated in nonlesional and lesional skin compared with healthy skin. Conversely, expression of TJ adaptor molecules (eg, MARVELD1, MARVELD2, ZO-1 [TJP-1] and ZO-2 [TJP-2]), which mediate the connection of intercellular junctions to cytoskeletal components, is significantly upregulated in lesional compared with nonlesional skin. From SC genes, filaggrin-1 is significantly downregulated in AD skin, and filaggrin-2 is significantly downregulated in lesional skin (Fig E4) . Furthermore, low-level keratins in nail beds and hair follicles (eg keratin 16) were overall upregulated in skin of patients with AD, and keratins of the oral mucosa and esophagus were also upregulated in lesional skin (eg, keratins 6A, 6B, and 6C; Fig E5) . Similar expression signature changes were also observed in the GJ and desmosome families, where genes that are expressed at very low levels or constitutively not expressed in healthy skin, such as GJB2, GJB6, DSC2, and DSG3, are significantly upregulated in lesions. However, genes expressed at high levels in healthy skin, such as GJB4, GJC3, and DSG2, are significantly downregulated in nonlesional AD skin, with further downregulation in lesional skin (Fig E5) .
We did not observe any clustering or dependence of differentially expressed genes as a function of either IgE levels or SCORAD scores of the patients.
FIG E1.
Schematics of study design and methodology. Swabs and biopsy specimens from the same skin area collected from patients with AD (n 5 13) and healthy control subjects (n 5 7) were processed, sequenced, and analyzed in parallel for global microbiome and transcriptomics. To reduce multiple testing, we then focused on Staphylococcus species on the one hand and skin barrier genes on the other hand for more detailed analysis and correlation. (Fig E2, A) separates healthy skin samples from those from patients with AD (both lesional and nonlesional AD) and, to a lesser extent, lesional from nonlesional samples, whereas 3-component PCA clustering (Fig E2, B) of skin transcriptome differentiates between all 3 skin groups. PC, Principal component. C-E, Hierarchical clustering of the global skin microbiome (Fig E2, C) separates AD lesional and nonlesional samples from healthy skin, with one exception, whereas for transcriptomics, the clustering of all genes ( Fig  E2, D) separates lesional samples from the others, but clustering of only the top 100 genes (Fig E2, E) separates all 3 skin groups. HE, Healthy; LS, lesional AD; NL, nonlesional AD.
FIG E3. Different frequencies of Staphylococcus species.
A and B, Frequencies of Staphylococcus species show different abundance patterns in healthy, lesional AD, and nonlesional AD skin, with only S aureus most abundant in AD lesional samples, whereas S epidermidis is most abundant in nonlesional skin, and the other species are most abundant in healthy skin. C and D, S aureus frequency is negatively correlated with that of S epidermidis and all other staphylococci, which are positively correlated with each other, in lesional skin. Heat map of fold change expression values (FCH) is scaled from blue to red in Fig E3, B , and heat map of correlation coefficients (R) is scaled from orange to green in Fig E3, D. HE, Healthy; LS, lesional AD; NL, nonlesional AD. (Table E3) . A and C, Heat map clustering of TJ (Fig E4, A) and SC barrier (Fig E4, C) gene expression shows different patterns of differential expression. B, Most highly expressed TJ genes are significantly downregulated in lesional skin, whereas some TJ genes expressed at lower levels and in particular TJ adaptor genes (eg, TJP1) are upregulated in lesions. D, Among the SC genes, filaggrins are downregulated in AD skin compared with healthy skin and in particular in lesional skin, whereas the keratin genes show a mix of upregulation and downregulation in AD and lesional skin. HE, Healthy; LS, lesional AD; NL, nonlesional AD. (Fig E5, A) , desmosome (Fig E5, B) , and AJ skin barrier genes (Fig E5, C) show a mixed pattern of differential expression. HE, Healthy; LS, lesional AD; NL, nonlesional AD. 
